Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Lamictal – Approved Treatment for Epilepsy and Bipolar

Drug (brand / generic)

Lamictal / lamotrigine

Company

GlaxoSmithKline

Therapy Class

Antiepileptic

Product Description

Sodium channel inhibitor

Current Indication

Epilepsy

Market Sector

Neurology

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top